These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2406326)

  • 1. Suppression by ingested eicosapentaenoic acid of the increases in nasal mucosal blood flow and eosinophilia of ryegrass-allergic reactions.
    Rangi SP; Serwonska MH; Lenahan GA; Pickett WC; Blake VA; Sample S; Goetzl EJ
    J Allergy Clin Immunol; 1990 Feb; 85(2):484-9. PubMed ID: 2406326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
    Baroody FM; Rouadi P; Driscoll PV; Bochner BS; Naclerio RM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L; Persson CG; Andersson M
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic reaction of the human nasal mucosa studied with laser Doppler flowmetry.
    Juliusson S; Bende M
    Clin Allergy; 1987 Jul; 17(4):301-5. PubMed ID: 2957119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals.
    Shamji MH; Bellido V; Scadding GW; Layhadi JA; Cheung DK; Calderon MA; Asare A; Gao Z; Turka LA; Tchao N; Togias A; Phippard D; Durham SR
    Allergy; 2015 Feb; 70(2):171-9. PubMed ID: 25377909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.
    Reinartz SM; Overbeek SE; Kleinjan A; van Drunen CM; Braunstahl GJ; Hoogsteden HC; Fokkens WJ
    Allergy; 2005 Oct; 60(10):1301-7. PubMed ID: 16134997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of provoked allergic reaction and histamine on nasal mucosal blood flow in humans.
    Bende M; Elner A; Ohlin P
    Acta Otolaryngol; 1984; 97(1-2):99-104. PubMed ID: 6689833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide.
    Bergmann-Hug K; Wirth R; Henseler M; Helbling A; Pichler WJ; Schnyder B
    Allergy; 2009 Nov; 64(11):1629-34. PubMed ID: 19627276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal mucosal blood flow after intranasal allergen challenge.
    Holmberg K; Bake B; Pipkorn U
    J Allergy Clin Immunol; 1988 Mar; 81(3):541-7. PubMed ID: 3346485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation.
    KleinJan A; Dijkstra MD; Boks SS; Severijnen LA; Mulder PG; Fokkens WJ
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):441-50. PubMed ID: 10069878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of nasal allergen challenge in evaluating the efficacy of intranasal corticosteroid treatment.
    Proud D; Riker DK; Togias A
    Clin Exp Allergy; 2010 May; 40(5):738-44. PubMed ID: 20337650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflex activation in allergen-induced nasal mucosal vascular reactions.
    Holmberg K; Bake B; Pipkorn U
    Acta Otolaryngol; 1989; 108(1-2):130-5. PubMed ID: 2763831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of changes in absorption of macromolecule through the nasal mucosa after antigen challenge in guinea pig model of allergic rhinitis.
    Numata T; Konno A; Terada N; Hanazawa T; Nagata H; Motosugi H; Okamoto Y
    Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1120-4. PubMed ID: 11130823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen.
    Walker KB; Serwonska MH; Valone FH; Harkonen WS; Frick OL; Scriven KH; Ratnoff WD; Browning JG; Payan DG; Goetzl EJ
    J Clin Immunol; 1988 Mar; 8(2):108-13. PubMed ID: 2453530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study.
    Horak F; Matthes H
    Ann Allergy; 1982 May; 48(5):305-8. PubMed ID: 7044195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge].
    Kupczyk M; Bocheńska-Marciniak M; Górski P; Kuna P
    Pneumonol Alergol Pol; 2002; 70(11-12):544-9. PubMed ID: 12884563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.